IL1B and obesity disorder: It lowered colonic levels of malondialdehyde (MDA), IL-1β, and IL-6, reduced eosinophil infiltration, substance P, and inducible nitric oxide synthase (iNOS) expression indicating its inhibitory effects on obesity-induced colonic inflammation.